News Search Results
Jul 29, 2025, 16:02 ET Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about our marketed products and development pipeline, visit
More news about: Dynavax Technologies
Jul 29, 2025, 13:43 ET Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
point-of-care testing is extending to urgent care centers, disaster relief zones, and at-home monitoring. While the market is recovering from the COVID-19 testing surge of 2020–2022, momentum continues thanks to emerging technologies and the expanding need for fast, accurate, and accessible diagnostics.
More news about: Kalorama Information
Jul 29, 2025, 12:34 ET Hansa Biopharma announces key executive appointments to support continued growth
responsibility and crisis and issues management. During this time, she successfully implemented agreements and influenced several health policies during the COVID-19 pandemic. In addition, Kerstin has held several positions with SwedenBIO, including member of the board, and multiple roles with LIF (Swedish Pharmaceutical
More news about: Hansa Biopharma AB
Jul 29, 2025, 12:30 ET Hansa Biopharma announces key executive appointments to support continued growth
responsibility and crisis and issues management. During this time, she successfully implemented agreements and influenced several health policies during the COVID-19 pandemic. In addition, Kerstin has held several positions with SwedenBIO, including member of the board, and multiple roles with LIF (Swedish Pharmaceutical
More news about: Hansa Biopharma AB
Jul 29, 2025, 10:26 ET American Property Casualty Insurance Association: WHAT YOU CAN DO ABOUT THE COST OF INSURANCE WHEN EVERYTHING IS GETTING MORE EXPENSIVE
legacy dating back 150 years. Sampson has led the industry through some of the most consequential insurance issues of the last decade, including the COVID-19 response, preserving state statutory accounting during once-in-a-generation tax reform, and ensuring that the Dodd-Frank Act recognized the strong
More news about: American Property Casualty Insurance Association
Jul 29, 2025, 10:15 ET Molecular Diagnostics Market to Hit USD 33.7 Billion by 2032, Growing at 7.3% CAGR | SkyQuest Technology Consulting
genetic material.By application, infectious disease diagnostics dominate owing to the global rise in infectious diseases such as COVID-19, HIV, tuberculosis, and influenza, driving demand for rapid, accurate, and scalable testing solutions.By end user, diagnostic laboratories
More news about: SkyQuest Technology
Jul 29, 2025, 09:00 ET New Report: U.S. Food Manufacturing Sees $15B Investment Boom but Tariffs and Labor Woes Threaten Growth
investment.Growth Trends by Industry SubsectorNotable employment growth has occurred in the following industry subsectors since prior to the Covid-19 pandemic. Animal Food Manufacturing leads long-term growth (+17%), driven by rising demand for premium pet food.Bakeries
More news about: Global Location Strategies
Jul 29, 2025, 08:00 ET AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
consistent with the known safety profile of each individual therapy alone. The most common adverse events in any grade were neutropenia, hemorrhage, and COVID-19 in patients administered VENCLEXTA plus acalabrutinib. The most frequent Grade 3 or higher adverse event was neutropenia seen in 26.8% of patients.
More news about: AbbVie
Jul 29, 2025, 07:30 ET NAPCO Security Technologies CEO & Founder Richard Soloway Named 2025 Security Innovator
trends, and anticipated product performance. These forward-looking statements include, but are not limited to, statements relating to the impact of COVID-19 pandemic; the growth of recurring service revenue and annual run rate; the introduction of new access control and locking products; the opportunities
More news about: NAPCO Security Technologies, Inc.
Jul 29, 2025, 07:00 ET New Report Shows Student Academic Recovery Remains Elusive
Curriculum Associates finds that five years after the onset of the COVID-19 pandemic, academic recovery has stalled nationwide, and achievement gaps have widened. The
More news about: Curriculum Associates, LLC
Jul 29, 2025, 07:00 ET CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
FDA Emergency Use Authorization in the United States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved or cleared in the United States.
More news about: Cytosorbents Corp
Jul 29, 2025, 06:45 ET Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL
decreased platelet count (29%), diarrhea (24%), COVID-19 (22%), bruising (21%), cough (20%). Mantle Cell Lymphoma Serious ARs occurred in 38% of patients. Serious ARs occurring in ≥2% of patients were pneumonia (14%), COVID-19 (4.7%), musculoskeletal pain (3.9%), hemorrhage
More news about: Eli Lilly and Company
Jul 29, 2025, 05:53 ET Seegene präsentiert das weltweit erste vollautomatisierte PCR-System und läutet auf der ADLM 2025 eine globale diagnostische Paradigmenwende ein
und Vertrieb im Zusammenhang mit syndromischen Echtzeit-PCR-Technologien. Dieses Fachwissen wurde, während der COVID-19-Pandemie besonders deutlich, als Seegene mehr als 340 Millionen COVID-19-Tests an mehr als 100 Länder weltweit lieferte. Das Hauptmerkmal der syndromischen Echtzeit-PCR-Technologie von
More news about: Seegene Inc.
Jul 29, 2025, 02:38 ET Seegene presenta la primera automatización PCR desatendida del mundo, iniciando un cambio de paradigma global en el diagnóstico en ADLM 2025
y comercialización de tecnologías de pruebas sindrómicas de PCR en tiempo real. Esta experiencia se destacó especialmente durante la pandemia de COVID-19, cuando Seegene proporcionó más de 340 millones de pruebas a más de 100 países. La característica principal de su tecnología sindrómica de PCR en tiempo
More news about: Seegene Inc.
Jul 29, 2025, 02:00 ET AudioCodes Reports Second Quarter 2025 Results and Declares Semi-Annual Dividend of 20 cent per share
of AudioCodes to successfully integrate the products and operations of acquired companies into AudioCodes' business; possible adverse impact of the COVID-19 pandemic on our business and results of operations; the effects of the current terrorist attacks by Hamas in Israel,
More news about: AudioCodes
Jul 28, 2025, 21:01 ET A Seegene revela a primeira automação de PCR autônoma do mundo, iniciando uma mudança de paradigma de diagnóstico global na ADLM 2025
tecnologias de PCR sindrômica em tempo real. Essa experiência foi particularmente destacada durante a pandemia de COVID-19, quando a Seegene forneceu mais de 340 milhões de testes de COVID-19 para mais de 100 países em todo o mundo. A principal característica da tecnologia de PCR sindrômica em tempo real
More news about: Seegene Inc.
Jul 28, 2025, 17:55 ET Vaccines: Mythology, Ideology, and Reality, New Book by John Leake and Peter A. McCullough
The Courage to Face COVID-19. Peter A. McCullough, MD, MPH, is an internist, cardiologist, and epidemiologist who has been a leader in the medical response to COVID-19. He has published dozens of peer-reviewed papers on COVID-19 and commented on the medical
More news about: Skyhorse Publishing
Jul 28, 2025, 16:15 ET Simpson Manufacturing Co., Inc. Announces 2025 Second Quarter Financial Results and Reaffirms 2025 Guidance
supply shortages on our operations and the operations of our customers, suppliers and business partners, the effect of a global pandemic such as the COVID-19 pandemic or other widespread public health crisis and their effects on the global economy as well as those discussed in the "Risk Factors" and " Management's
More news about: Simpson Manufacturing Co., Inc.
Jul 28, 2025, 09:49 ET Seegene presenta all'ADLM 2025 il primo sistema al mondo di PCR in completa automazione senza supervisione, innescando un cambiamento di paradigma diagnostico globale.
alle tecnologie real-time PCR sindromiche. Questa competenza è apparsa particolarmente evidente durante la pandemia di COVID-19, quando Seegene ha fornito oltre 340 milioni di test COVID-19 in più di 100 paesi in tutto il mondo. La tecnologia PCR sindromica di Seegene consente la rilevazione simultanea di
More news about: Seegene Inc.
Jul 28, 2025, 09:39 ET Seegene presenta en ADLM 2025 la primera automatización PCR autónoma del mundo
tecnologías de PCR sindrómica en tiempo real. Esta experiencia se puso especialmente de manifiesto durante la pandemia de COVID-19, cuando Seegene suministró más de 340 millones de pruebas de COVID-19 a más de 100 países de todo el mundo. La característica principal de la tecnología PCR sindrómica en tiempo real
More news about: Seegene Inc.
Jul 28, 2025, 09:26 ET Seegene dévoile la première solution d'automatisation de PCR sans surveillance au monde, amorçant un changement de paradigme en matière de diagnostic lors du salon ADLM 2025
dans le domaine des technologies PCR syndromique en temps réel. Ces compétences ont été particulièrement mises en évidence lors de la pandémie de COVID-19, lorsque Seegene a fourni plus de 340 millions de tests à plus de 100 pays à travers le monde. La principale caractéristique de la technologie PCR
More news about: Seegene Inc.
Jul 28, 2025, 09:12 ET Aptitude Secures $9M Partnership with BARDA to Develop Rapid Molecular Diagnostic for Ebolaviruses and Marburg Viruses
disease detection and treatment. Its mission is to democratize diagnostics by providing actionable lab-quality results, anywhere, in minutes. The Metrix COVID-19 test and the Metrix COVID/Flu test are commercially available FDA-authorized molecular tests on the platform. Aptitude has an extensive development
More news about: Aptitude Medical Systems, Inc.
Jul 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers - WOOF
in period-over-period net sales from physical locations and digital sites that have been open for the applicable period. In the wake of the COVID-19 pandemic, Petco consistently touted the benefits of pandemic-related tailwinds on its growth and profitability, including comparable sales growth,
More news about: Pomerantz LLP
Jul 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against iRobot Corporation and Certain Officers - IRBT
was the first commercially successful RVC, iRobot's business has steadily declined over the past decade, apart from a brief sales bump during the COVID-19 pandemic. Competitors from China undercut the luxury-priced Roomba, while other consumer electronics firms like
More news about: Pomerantz LLP
Jul 26, 2025, 09:00 ET Seegene Lansir Otomatisasi PCR Pertama di Dunia Tanpa Bantuan Manusia, Ubah Paradigma Industri Diagnostik Global di ADLM 2025
teknologi syndromic real-time PCR selama lebih dari 20 tahun. Pengalaman Seegene terbukti ketika pandemi Covid-19 terjadi. Saat itu, Seegene menyediakan lebih dari 340 juta alat tes Covid-19 untuk lebih dari 100 negara di seluruh dunia. Teknologi PCR Seegene mampu memeriksa 14 patogen yang menyebabkan
More news about: Seegene Inc.